Ivy Blog

Last month, leaders from the Ivy Brain Tumor Center traveled to Madrid, Spain, for the European Investigator Meeting for the Phase 3 Gliofocus Study. The meeting brought together 136 participants from 48 clinical trial sites across 13 countries to align on study goals, review protocols, and address challenges to ensure consistency and collaboration across all locations.

Our team of brain tumor experts have compiled everything you need to know about our clinical trials, including the rationale behind the novel drugs and devices we're investigating as well as some of the initial results we're seeing in brain cancer patients.

At the 26th Annual Meeting of the Society for Neuro-Oncology (SNO), the Ivy Brain Tumor Center’s team of brain tumor specialists and scientists will be giving 11 presentations based on our preclinical and clinical research findings. The abstracts were published in the journal of Neuro-Oncology.